There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
Mierau, J., et al.: J. Med. Chem., 30, 494 (1987); Schilling, J.C., et al.: Clin. Pharmacol. Ther., 51, 541 (1992);
Synonyms
Pramipexole(7R)-N-dimer
Application Notes
(6S,7R)-4,5,6,7-Tetrahydro-N6-propyl-N7-[(6S)-4,5,6,7-tetrahydro-6-(propylamino)-2-benzothiazolyl]-2,6,7-benzothiazoletriamine is a impurity of Pramipexole, a dopamine-D2-receptor agonist. Pramipexole (Mirapex, Mirapexin, Sifrol) is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson?s disease (PD) and restless legs syndrome (RLS)
Hazard Compound
Refer MSDS for complete information.
Overview
(6S,7R)-4,5,6,7-Tetrahydro-N6-propyl-N7-[(6S)-4,5,6,7-tetrahydro-6-(propylamino)-2-benzothiazolyl]-2,6,7-benzothiazoletriamine is a impurity of Pramipexole, a dopamine-D2-receptor agonist. Pramipexole (Mirapex, Mirapexin, Sifrol) is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson?s disease (PD) and restless legs syndrome (RLS)
![N,N'-(4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diyl)dipropionamide](https://structures.clearsynth.com/CS-O-54099.PNG)
